More than 170,000 people still sought medical help for acute respiratory infection (ARI), including 22,000 with ...

At ESCMID Global 2025 in Vienna, AstraZeneca will present a comprehensive data package from its Vaccines & Immune Therapies portfolio, featur ...

(NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for virology and immunology ...

"My daughter was like a walking virus collection," says a visibly exhausted mother in Nairobi. Her four-year-old tested positive for not one, but four different viruses simultaneously – Influenza A, ...

Moderna, Inc. (NASDAQ:MRNA) today announced that the Company will present research across multiple infectious disease areas, including COVID-19, influenza, respiratory syncytial virus (RSV), ...

British pharmaceutical giant GlaxoSmithKline and rival Pfizer have agreed to end a lawsuit that alleged Pfizer's respiratory ...

While the ‘official’ flu season may still be a month or two away, reports indicate a rise in respiratory illnesses like the ...

The authors assessed the patient characteristics associated with RSV vaccination among older adults hospitalized during the ...

Pfizer’s RSV vaccine Abrysvo receives European approval to help protect adults aged 18-59 against RSV lower respiratory tract disease: New York Wednesday, April 2, 2025, 09:00 H ...

CAMBRIDGE, MA / ACCESS Newswire / March 31, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the Australian Therapeutic Goods ...

Just four cases of bird flu in backyard flocks have been confirmed in this area, and risk to humans is very low. Humans can't pass it to each other.

The Triad's three main healthcare systems separately announced Wednesday they will lift at 7 a.m. Thursday their respiratory virus visitor restrictions on children under age 13.